Skip to main content

Table 2 Adverse events by treatment

From: Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy

Adverse event RT CCRT CCRT + CT P value
(Grade),N = 13 (Grade),N = 15 (Grade),N = 5
3 4 3 4 3 4
Neutropenia 2 0 2 5 3 2 0.002
Anemia 1 0 2 0 1 0 0.128
Thrombocytopenia 1 0 3 1 1 1 0.079
Nausea/vomiting 1 0 2 0 1 0 0.446
Diarrhea 1 0 2 1 1 0 0.383
Genitourinary 1 0 1 0 1 0 0.673
Neurotoxicity 0 0 0 0 0 0 1
Renal 0 0 0 0 0 0 1
Hepatic 0 0 1 0 1 0 0.339
  1. Abbreviations:RT radiotherapy, CCRT chemoradiotherapy, CCRT + CT chemoradiotherapy plus consolidation chemotherapy.